28 related articles for article (PubMed ID: 38552439)
21. Hydrogen sulfide dysfunction in metabolic syndrome-associated vascular complications involves cGMP regulation through soluble guanylyl cyclase persulfidation.
Smimmo M; Casale V; Casillo GM; Mitidieri E; d'Emmanuele di Villa Bianca R; Bello I; Schettino A; Montanaro R; Brancaleone V; Indolfi C; Cirino G; Di Lorenzo A; Bucci M; Panza E; Vellecco V
Biomed Pharmacother; 2024 May; 174():116466. PubMed ID: 38552439
[TBL] [Abstract][Full Text] [Related]
22. Hydrogen sulfide and endothelium-dependent vasorelaxation.
Bełtowski J; Jamroz-Wiśniewska A
Molecules; 2014 Dec; 19(12):21183-99. PubMed ID: 25521118
[TBL] [Abstract][Full Text] [Related]
23. Hydrogen sulfide, an enhancer of vascular nitric oxide signaling: mechanisms and implications.
Szabo C
Am J Physiol Cell Physiol; 2017 Jan; 312(1):C3-C15. PubMed ID: 27784679
[TBL] [Abstract][Full Text] [Related]
24. The Impact of the Nitric Oxide (NO)/Soluble Guanylyl Cyclase (sGC) Signaling Cascade on Kidney Health and Disease: A Preclinical Perspective.
Krishnan SM; Kraehling JR; Eitner F; Bénardeau A; Sandner P
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29890734
[TBL] [Abstract][Full Text] [Related]
25. The Endothelium-Dependent Nitric Oxide-cGMP Pathway.
Mónica FZ; Bian K; Murad F
Adv Pharmacol; 2016; 77():1-27. PubMed ID: 27451093
[TBL] [Abstract][Full Text] [Related]
26. Role of the nitric oxide-soluble guanylyl cyclase pathway in obstructive airway diseases.
Dupont LL; Glynos C; Bracke KR; Brouckaert P; Brusselle GG
Pulm Pharmacol Ther; 2014 Oct; 29(1):1-6. PubMed ID: 25043200
[TBL] [Abstract][Full Text] [Related]
27.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
28.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
